General Information of Disease (ID: DISW84TN)

Disease Name Cerebral X-linked adrenoleukodystrophy
Disease Class 5C57: Peroxisomal disease
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISW84TN: Cerebral X-linked adrenoleukodystrophy
ICD Code
ICD-11
ICD-11: 5C57.1
Disease Identifiers
MONDO ID
MONDO_0010247
UMLS CUI
C2026514
MedGen ID
1708324
Orphanet ID
139396

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Leriglitazone DMQFD42 Phase 3 Small molecule [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 ClinicalTrials.gov (NCT05819866) A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy. U.S.National Institutes of Health.